↓ Skip to main content

A randomized, double-blind, placebo-controlled phase 2 study evaluating the efficacy and safety of romiplostim treatment of patients with low or intermediate-1 risk myelodysplastic syndrome receiving…

Overview of attention for article published in Journal of Hematology & Oncology, November 2012
Altmetric Badge

Citations

dimensions_citation
59 Dimensions

Readers on

mendeley
50 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
A randomized, double-blind, placebo-controlled phase 2 study evaluating the efficacy and safety of romiplostim treatment of patients with low or intermediate-1 risk myelodysplastic syndrome receiving lenalidomide
Published in
Journal of Hematology & Oncology, November 2012
DOI 10.1186/1756-8722-5-71
Pubmed ID
Authors

Eunice S Wang, Roger M Lyons, Richard A Larson, Sunil Gandhi, Delong Liu, Carmen Matei, Bart Scott, Kuolung Hu, Allen S Yang

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 50 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 50 100%

Demographic breakdown

Readers by professional status Count As %
Other 6 12%
Student > Ph. D. Student 6 12%
Student > Master 5 10%
Researcher 4 8%
Student > Doctoral Student 3 6%
Other 11 22%
Unknown 15 30%
Readers by discipline Count As %
Medicine and Dentistry 19 38%
Pharmacology, Toxicology and Pharmaceutical Science 2 4%
Unspecified 2 4%
Nursing and Health Professions 2 4%
Engineering 2 4%
Other 3 6%
Unknown 20 40%